Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.3K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-nucleus multiomic atlas of ALS primary motor cortex nominates neuroprotective WDR49-expressing astrocytes.

Research square·2026
Same author

Optimization of cortico-cortical spectral response analysis parameters for seizure onset zone localization.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Identification of quinolinyl-containing dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors with moderate potency towards acetylcholinesterase.

Results in chemistry·2026
Same author

Tuning the open-close equilibrium of Cereblon with small molecules influences protein degradation.

bioRxiv : the preprint server for biology·2026
Same author

Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

British journal of cancer·2025
Same author

Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

British journal of cancer·2025
Same journal

Advancing Biochemical Molecule Registration, Representation and Search for New Drug Modalities.

Journal of chemical information and modeling·2026
Same journal

A Unified Molecular Graph and Protein Language Model Framework for Predicting Human Drug-Hormone Receptor Interactions with Structure-Aware Validation.

Journal of chemical information and modeling·2026
Same journal

Intricate Role of Cholesterol in Membrane Fusion.

Journal of chemical information and modeling·2026
Same journal

tmGNN-XAI: An Explainable Graph Neural Network Tool for Predicting Electronic Properties of Transition Metal Complexes from SMILES.

Journal of chemical information and modeling·2026
Same journal

QSAR in the Browser: An Interactive Cheminformatics Web Application.

Journal of chemical information and modeling·2026
Same journal

FoldDoF: Utilizing the Primary Degrees of Freedom of Protein Backbone for Geometric Modeling and Generation.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Nov 4, 2025

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.5K

Automated Generation of Novel Fragments Using Screening Data, a Dual SMILES Autoencoder, Transfer Learning and Syntax

Alan E Bilsland1, Kirsten McAulay1, Ryan West1

  • 1Beatson Drug Discovery Unit, Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, U.K.

Journal of Chemical Information and Modeling
|May 24, 2021
PubMed
Summary
This summary is machine-generated.

Fragment-based drug discovery utilizes artificial neural networks for novel fragment library design. A dual autoencoder model improves molecular features and generates candidate privileged fragments more effectively.

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

6.2K
Automated Robotic Liquid Handling Assembly of Modular DNA Devices
11:22

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

12.6K

Related Experiment Videos

Last Updated: Nov 4, 2025

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

3.5K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

6.2K
Automated Robotic Liquid Handling Assembly of Modular DNA Devices
11:22

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

12.6K

Area of Science:

  • Computational Chemistry
  • Medicinal Chemistry
  • Artificial Intelligence in Drug Discovery

Background:

  • Fragment-based hit identification (FBHI) offers greater chemical space coverage than high-throughput screening but relies heavily on library design.
  • Designing effective fragment libraries involves optimizing solubility, stability, diversity, and synthetic tractability, which is a time-consuming process.

Purpose of the Study:

  • To develop and evaluate an autoencoder model for de novo fragment library design.
  • To improve the quality and diversity of generated fragments by simultaneously reconstructing SMILES and chemical fingerprints.

Main Methods:

  • A recurrent neural network-based autoencoder model was trained on a large dataset of commercial fragments.
  • Transfer learning was used to train a classifier on frequent hitter fragments.
  • A particle swarm optimization approach was employed to sample and evaluate generated molecules.
  • A syntax-correction procedure was implemented during training to enhance generative performance.

Main Results:

  • The dual autoencoder model generated valid SMILES with improved features, including higher synthetic accessibility and a novel Feature Complexity (FeCo) score.
  • Generative performance was enhanced by incorporating a syntax-correction procedure during training.
  • The model successfully generated a library of novel candidate privileged fragments.

Conclusions:

  • Artificial neural networks, specifically dual autoencoders, are effective tools for fragment library design.
  • The developed model improves the quality and relevance of generated fragments for drug discovery.
  • This approach accelerates the design of novel fragment libraries with desirable properties.